| Name | Title | Contact Details |
|---|---|---|
Peter Wang |
Chief Technology Officer | Profile |
Capitol Drugs is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Sherman Oaks, CA. To find more information about Capitol Drugs, please visit www.capitoldrugs.com
We provide gender-affirming hormone therapy via telehealth for the trans-community across the United States. Based in Denver, CO, Plume is trans-founded and has received backing from top-tier venture capital. Our mission is to create deeply affirming direct-to-consumer pharmaceutical services for the trans and broader queer community. We are currently hiring talented, inspired and mission-aligned individuals.
Century Park Associates is a Chattanooga, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
BetterMynd is an online therapy platform for college students that aims to increase accessibility to mental health services and reduce stigma surrounding mental distress in young adults.
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.